These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 15632469

  • 1. [Strontium Ranelate as a new therapeutic agent for osteoporosis].
    Imanishi Y, Nishizawa Y.
    Clin Calcium; 2005 Jan; 15(1):25-8. PubMed ID: 15632469
    [Abstract] [Full Text] [Related]

  • 2. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
    Marie PJ.
    Bone; 2006 Feb; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
    Ortolani S, Vai S.
    Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
    [Abstract] [Full Text] [Related]

  • 6. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
    Adami S.
    Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
    [Abstract] [Full Text] [Related]

  • 7. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
    Neuprez A, Hiligsmann M, Scholtissen S, Bruyere O, Reginster JY.
    Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
    [Abstract] [Full Text] [Related]

  • 8. Addressing and meeting the needs of osteoporotic patients with strontium ranelate: a review.
    Boonen S.
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S21-7. PubMed ID: 16735842
    [Abstract] [Full Text] [Related]

  • 9. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E.
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
    Dimai HP.
    Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
    [Abstract] [Full Text] [Related]

  • 13. [Therapeutic agents for disorders of bone and calcium metabolism. Osteoporotic fracture prevention by strontium ranelate].
    Nakamura T.
    Clin Calcium; 2007 Jan; 17(1):80-7. PubMed ID: 17211097
    [Abstract] [Full Text] [Related]

  • 14. Continuous broad protection against osteoporotic fractures with strontium ranelate.
    Ferrari S.
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv20-4. PubMed ID: 19783590
    [Abstract] [Full Text] [Related]

  • 15. Osteoporosis: from early fracture prevention to better bone health with strontium ranelate.
    Cortet B.
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv14-9. PubMed ID: 19783589
    [Abstract] [Full Text] [Related]

  • 16. A new treatment for post-menopausal osteoporosis: strontium ranelate.
    Rizzoli R.
    J Endocrinol Invest; 2005 Oct; 28(8 Suppl):50-7. PubMed ID: 16323829
    [Abstract] [Full Text] [Related]

  • 17. Improvement in bone strength parameters. The role of strontium ranelate.
    Tournis S.
    J Musculoskelet Neuronal Interact; 2007 Oct; 7(3):266-7. PubMed ID: 17947810
    [Abstract] [Full Text] [Related]

  • 18. [Strontium ranelate].
    Masaki H, Miki T.
    Clin Calcium; 2006 Jan; 16(1):137-44. PubMed ID: 16397364
    [Abstract] [Full Text] [Related]

  • 19. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML, Spector TD, Brixen K, Goemaere S, Cormier C, Balogh A, Delmas PD, Meunier PJ.
    Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
    [Abstract] [Full Text] [Related]

  • 20. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
    Shiraki M.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():447-53. PubMed ID: 18161147
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.